Metabolomics in cancer biomarker discovery: current trends and future perspectives.
about
Animal-Free Chemical Safety AssessmentBlood transcriptomics and metabolomics for personalized medicine"OMIC" tumor markers for breast cancer: A reviewApplication of metabolomics in drug resistant breast cancer researchHeterogeneity of glycolysis in cancers and therapeutic opportunities.Metabolomics of Head and Neck Cancer: A Mini-ReviewMetabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic reviewPathomx: an interactive workflow-based tool for the analysis of metabolomic data.Statistical methods for handling unwanted variation in metabolomics databiosigner: A New Method for the Discovery of Significant Molecular Signatures from Omics Data.Liquid Chromatography Mass Spectrometry-Based Metabolite Pathway Analyses of Myeloma and Non-Hodgkin's Lymphoma PatientsDevelopment and in silico evaluation of large-scale metabolite identification methods using functional group detection for metabolomics.Structural mass spectrometry of tissue extracts to distinguish cancerous and non-cancerous breast diseases.Analytical methods in untargeted metabolomics: state of the art in 2015.Do not just do it, do it right: urinary metabolomics--establishing clinically relevant baselines.Biomarker identification and pathway analysis by serum metabolomics of lung cancer.The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancerMetabolic signatures differentiate ovarian from colon cancer cell lines.Modeling cancer metabolism on a genome scale.Urine metabolome profiling of immune-mediated inflammatory diseases.Three plasma metabolite signatures for diagnosing high altitude pulmonary edema.Metabolic responses induced by DNA damage and poly (ADP-ribose) polymerase (PARP) inhibition in MCF-7 cells.Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging.Metabolic profiling reveals potential metabolic markers associated with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cellsMetabolomic signature of brain cancer.To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients.Metabolomic profiling of breast tumors using ductal fluid.Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma.Cancer biomarker discovery: current status and future perspectives.Cancer metabolomics in basic science perspective.Next-generation technologies for multiomics approaches including interactome sequencing.Mass spectrometric based approaches in urine metabolomics and biomarker discovery.Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.Current Trends and Innovations in Bioanalytical Techniques of Metabolomics.Mitochondrial dynamics regulating chemoresistance in gynecological cancers.NMR metabolomics of renal cancer: an overview.Plasma metabolite abundances are associated with urinary enterolactone excretion in healthy participants on controlled diets.Metabolomics and Integrative Omics for the Development of Thai Traditional Medicine.Advances in Applications of Metabolomics in Pluripotent Stem Cell Research.Amino acid profiling as a method of discovering biomarkers for early diagnosis of cancer.
P2860
Q26738977-4018EC60-B03B-4B96-8739-A57B646CCC1DQ26772073-02CC1DA0-696C-4412-AB88-5D34447E513DQ26773092-9635BE8B-0DE5-489B-9A7E-74D1A1F8C346Q26866291-90DF29CD-6CEF-4EBE-A4CE-3529E59EDE2FQ27693375-E49E0E31-40E3-4742-8AD4-89D10F180883Q28069660-B010CB3F-89A1-4694-B4AD-3EEA7207BF96Q30234900-0306E06E-F129-479B-AC38-1721F9D6FF03Q30876427-4DA08349-7871-4E66-A061-0E842B4282BFQ30894998-961C0C02-0722-47C5-9D8C-D53E7A7E3C10Q31116678-26195487-204D-4A77-9EA4-AD115FCA61C0Q33738082-F9D60B1B-5C2C-400E-9EC8-04E784E678A7Q33959026-D1332DD8-AD94-45DA-B022-008D07587AEFQ34282970-924D14A7-3454-4449-A37E-B51B445F62D4Q35149924-2A917C7E-6E9C-48AB-A0E5-49E482ACC105Q35161733-9888E80C-2A01-4D2D-B588-893F2C834798Q35557547-C45305D7-E675-458B-BBC4-8B58AC8FC12DQ35686588-6C24D732-CAFD-4A21-BEA7-9DD3EFAF1988Q35844833-70945D92-AA05-4665-92E6-84E99B6F502DQ35850350-060ED53F-BFED-4BEF-BE2A-722AE8559F91Q36127459-9B08DD1B-17D7-486F-9CD7-A58E72D61355Q36150268-62BFFF2B-0F3A-494B-A75C-C5727F4D6E64Q36164842-14DE1454-8D23-4BF0-B63C-85DE1CA2F7D3Q36200694-06A9A59E-AB7B-4992-975E-5BFAC463EDFAQ36216405-03A9D497-C7CF-4DEA-BB95-44E6A8A42E91Q36406413-9B1CB98A-5382-4323-B272-7C7D694BD9D8Q37225538-FCC10557-8BEA-477D-BD4F-DBCAC6252138Q37427026-A7CF9EB3-0CDF-42A4-B1F4-38E45C89FF05Q37484601-C6BF57B8-3A8C-4309-9B06-1E8CCD2392BEQ38187679-3214FA85-FD46-4F8B-842C-A25B3CDA2BC1Q38335800-5223FA67-2BCB-4470-A580-7A06195E2769Q38343369-C01F5D82-4D61-42D8-B52B-8C1061F4130AQ38424072-C75E8E06-1148-4829-8FCA-22742141DE7DQ38445925-3CC725F2-B250-424E-BC5A-A975F308AA38Q38580222-905CEA8F-AA0C-4BB8-9B2B-E678CFF62EA5Q38587869-B0135A55-56E0-4395-882F-71A0701B2DEEQ38591205-72BC94A5-CA69-4CE5-8A85-6D319508D8FFQ38624696-8B288556-FF29-4488-A1F8-847E593E2CDFQ38645656-915EECA2-4FE4-4DC7-9FDC-61647B970B88Q38654015-AF6E944B-B7A2-4A3A-870B-B60E9E37E84AQ38794979-604A6BB2-D6F0-4588-8CC2-3EECEC9F08AF
P2860
Metabolomics in cancer biomarker discovery: current trends and future perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Metabolomics in cancer biomarker discovery: current trends and future perspectives.
@en
type
label
Metabolomics in cancer biomarker discovery: current trends and future perspectives.
@en
prefLabel
Metabolomics in cancer biomarker discovery: current trends and future perspectives.
@en
P1476
Metabolomics in cancer biomarker discovery: current trends and future perspectives.
@en
P356
10.1016/J.JPBA.2013.08.041
P577
2013-09-14T00:00:00Z